Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report)

Although there is a significant reduction in atherosclerotic cardiovascular disease risk with statins, a higher risk of diabetes mellitus has been demonstrated in randomized clinical trials. The risk of incident diabetes with statins may be heterogeneous by presence of coronary artery calcium (CAC). We evaluated participants without prevalent diabetes at baseline from the MESA (Multi-Ethnic Study of Atherosclerosis), a prospective cohort study of subjects free of clinical cardiovascular disease at baseline.

Source: The American Journal of Cardiology - October 1, 2022 Category: Cardiology Authors: Mahmoud Al Rifai, Moyses Szklo, Jaideep Patel, Michael J. Blaha, Christie M. Ballantyne, Vera Bittner, Pamela Morris, John W. McEvoy, Michael D. Shapiro, Mouaz H. Al-Mallah, Philip Greenland, Salim S. Virani Source Type: research